Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?

Calcified Tissue International

Volumn 86, Issue 1, 2010, Pages 23-32

  Kolios, Leila ^a   Hoerster, Ann Kristin ^a   Sehmisch, Stephan ^a   Malcherek, Marie Christin ^a   Rack, Thomas ^a   Tezval, Mohammed ^a   Seidlova Wuttke, Dana ^a   Wuttke, Wolfgang ^a   Stuermer, Klaus Michael ^a   Stuermer, Ewa Klara ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Alendronate; Bisphosphonate; Estrogen; Metaphyseal fracture healing; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FRACTURE HEALING; HISTOPATHOLOGY; METAPHYSIS; MICRORADIOGRAPHY; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PLATE FIXATION; PRIORITY JOURNAL; PROPHYLAXIS; RAT; TIBIA OSTEOTOMY; TRABECULAR BONE;

ALENDRONATE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE PLATES; BONE REGENERATION; BONY CALLUS; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; FRACTURE FIXATION; FRACTURES, BONE; OSTEOPOROSIS; OSTEOTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TIBIA; TREATMENT OUTCOME; WOUND HEALING;

EID: 73649122393     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-009-9318-7     Document Type: Article

References (43)

1. S Savoca S D'Agosta G Lombardo 2007 Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II Minerva Ginecol 59 215 222 1:STN:280:DC%2BD2srlslKgsQ%3D%3D 17576400 (Pubitemid 47203884)
2. DD Thompson HA Simmons CM Pirie HZ Ke 1995 FDA guidelines and animal models for osteoporosis Bone 17 125 133 10.1016/8756-3282(95)97353-H
3. R Curtis J Goldhahn R Schwyn P Regazzoni N Suhm 2005 Fixation principles in metaphyseal bone-a patent based review Osteoporos Int 16 54 64 10.1007/s00198-004-1763-6 (Pubitemid 46232121)
4. HG Ahlborg O Johnell CH Turner G Rannevik MK Karlsson 2003 Bone loss and bone size after menopause N Engl J Med 349 327 334 10.1056/NEJMoa022464 12878739 (Pubitemid 36886238)
5. UT Iwaniec K Moore MF Rivera SE Myers SM Vanegas TJ Wronski 2008 A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats Osteoporos Int 18 351 362 10.1007/s00198-006-0240-9
6. L Claes A Veeser M Göckelmann U Simon A Ignatius 2009 A novel model to study metaphyseal bone healing under defined biomechanical conditions Arch Orthop Trauma Surg 129 923 928 10.1007/s00402-008-0692-9 18654792
7. O Johnell J Kanis 2005 Epidemiology of osteoporotic fractures Osteoporos Int 16 3 7 10.1007/s00198-004-1702-6 (Pubitemid 46232115)
8. E Dennison C Cooper 2000 Epidemiology of osteoporotic fractures Horm Res 54 58 63 1:CAS:528:DC%2BD3MXhs12rsrs%3D 11146381
9. RM McCann G Colleary C Geddis SA Clarke GR Jordan GR Dickson D Marsh 2008 Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model J Orthop Res 26 384 393 10.1002/jor.20505 17960650
10. YL Hao G Zhang YS Wang L Qin WY Hung K Leung FX Pei 2007 Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats Bone 41 631 638 10.1016/j.bone.2007.06.006 17652051 (Pubitemid 47385430)
11. P Augat U Simon A Liedert L Claes 2005 Mechanics and mechano-biology of fracture healing in normal and osteoporotic bone Osteoporos Int 16 36 43 10.1007/s00198-004-1728-9 (Pubitemid 46232119)
12. C Barrios LA Brostrom A Stark G Walheim 1993 Healing complications after internal fixation of trochanteric hip fractures: the prognostic value of osteoporosis J Orthop Trauma 7 438 442 10.1097/00005131-199310000-00006 1:STN:280:DyaK2c%2Fks1Wjug%3D%3D 8229380
13. JA Kanis N Burlet C Cooper PD Delmas JY Reginster F Borgstrom R Rizzoli 2008 European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos Int 19 399 428 10.1007/s00198-008-0560-z 1:STN:280:DC%2BD1c3itFekuw%3D%3D 18266020
14. KB Horwitz 2008 The year in basic science: update of estrogen plus progestin therapy for menopausal hormone replacement implicating stem cells in the increased breast cancer risk Mol Endocrinol 22 2743 2750 10.1210/me.2008-0291 1:CAS:528:DC%2BD1cXhsVKgt7bM 18845670
15. A Tarakida T Higuchi H Mizunuma 2007 Evidence of hormone replacement therapy for osteoporosis Clin Calcium 18 1434 1441
16. Y Cao S Mori T Mashiba MS Westmore L Ma M Sato T Akiyama L Shi S Komatsubara K Miyamoto H Norimatsu 2002 Raloxifene, estrogen and alendronate affect the processes of fracture repair differently in ovariectomized rats J Bone Miner Res 17 2237 2246 10.1359/jbmr.2002.17.12.2237 1:CAS:528: DC%2BD38XpsV2lsb4%3D 12469918
17. Y Cao S Mori T Mashiba Y Kaji T Manabe K Iwata K Miyamoto S Komatsubara T Yamamoto 2007 1Alpha, 25-dihydroxy-2beta(3-hydroxypropoxy)vitamin D3 (ED-71) suppressed callus modelling but did not interfere with fracture healing in rat femora Bone 40 132 139 10.1016/j.bone.2006.07.023 1:CAS:528:DC%2BD28Xht12ktrvM 16962400 (Pubitemid 44839343)
18. A Alakangas K Selander M Mulari J Halleen P Lehenkari J Mönkkönen J Salo K Väänänen 2001 Alendronate disturbs vesicular trafficking in osteoclasts Calcif Tissue Int 70 40 47 10.1007/s002230010047 11907706
19. DM Black SR Cummings DB Karpf JA Cauley DE Thompson MC Nevitt DC Bauer HK Genant WL Haskell R Marcus SM Ott JC Torner SA Quandt TF Reiss KE Ensrud 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group Lancet 348 1535 1541 10.1016/S0140-6736(96)07088-2 1:CAS:528:DyaK2sXisFCktQ%3D%3D 8950879 (Pubitemid 26411651)
20. HG Bone D Hosking JP Devogelaer JR Tucci RD Emkey RP Tonino JA Rodriguez-Portales RW Downs J Gupta AC Santora UA Liberman 2004 Ten years' experience with alendronate for osteoporosis in post menopausal women N Engl J Med 350 1189 1199 10.1056/NEJMoa030897 1:CAS:528:DC%2BD2cXit12rsLc%3D 15028823 (Pubitemid 38339363)
21. PM Chavassieux ME Arlot C Reda L Wei AJ Yates PJ Meunier 1997 Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodelling in patients with osteoporosis J Clin Invest 100 1475 1480 10.1172/JCI119668 1:CAS:528:DyaK2sXmt1Cqsb8%3D 9294113
22. DM Black AV Schwartz KE Ensrud JA Cauley S Levis SA Quandt S Satterfield RB Wallace DC Bauer L Palermo LE Wehren A Lombardi AC Santora SR Cummings 2006 Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial JAMA 296 2927 2938 10.1001/jama.296.24.2927 1:CAS:528:DC%2BD2sXnvVGh 17190893 (Pubitemid 46021497)
23. E van der Poest Clement M van Engeland H Ader JC Roos P Patka P Lips 2002 Alendronate in the prevention of bone loss after a fracture of the lower leg J Bone Miner Res 17 2247 2255 10.1359/jbmr.2002.17.12.2247 12469919
24. E Van der Poest Clement P Patka K Vandormael H Haarman P Lips 2000 The effect of alendronate on bone mass after distal forearm fracture J Bone Miner Res 15 586 593 10.1359/jbmr.2000.15.3.586 10750574
25. AL Boskey L Spevak RS Weinstein 2008 Spectroscopic markers of bone quality in alendronate-treated postmenopausal women Osteoporos Int 20 793 800 10.1007/s00198-008-0725-9 18769963
26. JA Guy M Shea CP Peter R Morrissey WC Hayes 1993 Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties Calcif Tissue Int 53 283 288 10.1007/BF01320915 1:CAS:528:DyaK2cXpsFOjtQ%3D%3D 8275358
27. D Seidlova-Wuttke O Hesse H Jarry V Christoffel B Spengler T Becker W Wuttke 2003 Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimifuga racemosa) extract: comparison with estradiol-17beta Eur J Endocrinol 149 351 362 10.1530/eje.0.1490351 1:CAS:528:DC%2BD3sXoslKht7s%3D 14514351 (Pubitemid 37304707)
28. TJ Wronski PL Lowry CC Walsh LA Ignaszewski 1985 Skeletal alterations in ovariectomized rats Calcif Tiss Int 37 324 328 10.1007/BF02554882 1:STN:280:DyaL2M3lsVSmuw%3D%3D (Pubitemid 15034552)
29. Stuermer EK, Sehmisch S, Rack T, Wenda E, Seidlova-Wuttke D, Tezval M, Wuttke W, Frosch KH, Stuermer KM (2009) Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat. Lang Arch Surg (in press)
30. BA Rahn 1976 The fluorochrome sequence labeling of the bone Nova Acta Leopold 44 249 255
31. EK Stürmer D Seidlova-Wuttke S Sehmisch T Rack J Wille KH Frosch W Wuttke KM Stürmer 2006 Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene J Bone Miner Res 21 89 96 10.1359/JBMR.050913 16355277 (Pubitemid 43023230)
32. RK Schenk 1965 The histological preparation of undecalcified bone Acta Anat 60 3 19 10.1159/000142633 1:STN:280:DyaF2M%2FpsF2rsg%3D%3D 14291395
33. AM Parfitt MK Drezner FH Glorieux JA Kanis H Malluche PJ Meunier SM Ott RR Recker 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee J Bone Miner Res 2 595 610 1:STN:280:DyaL1czjvVemsQ%3D%3D 3455637
34. VS Nikolaou N Efstathopoulos G Kontakis NK Kanakaris PV Giannoudis 2009 The influence of osteoporosis in femoral fracture healing time Injury 40 663 668 10.1016/j.injury.2008.10.035 19324360
35. ME Bolander R Sabbagh C Jeng 1992 Estrogen treatment during fracture repair strengthens healing callus in an osteoporotic model Trans Orthop Res Soc 17 138
36. G Schmidmaier B Wildemann H Bail M Lucke T Fuchs A Stemberger A Flyvberg NP Haas M Raschke 2001 Local application of growth factors insulin-like growth factor-1 and transforming growth factor-β from a biodegradable poly (d, l-lactide) coating of osteosynthetic implants accelerated fracture healing in rats Bone 28 341 350 10.1016/S8756-3282(00)00456-7 1:CAS:528: DC%2BD3MXjtFGgtro%3D 11336914 (Pubitemid 32390106)
37. P Aspenberg K Wermelin P Tengwall A Fahlgren 2008 Additive effects of PTH and bisphoshonates on the bone healing response to metaphyseal implants in rats Acta Orthop 79 111 115 10.1080/17453670710014851 18283582 (Pubitemid 351271892)
38. EF Morgan ZD Mason G Bishop AD Davis NA Wigner LC Gerstenfeld TA Einhorn 2008 Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing Bone 43 1031 1038 10.1016/j.bone.2008.07.251 1:CAS:528:DC%2BD1cXhsVKltrbK 18761113
39. E Tsiridis EF Morgan JM Bancroft M Song M Kain L Gerstenfeld TA Einhorn ML Bouxsein P Tornetta 3rd 2007 Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing J Orthop Res 25 1193 1203 10.1002/jor.20420 1:CAS:528:DC%2BD2sXhtVCqsLvN 17506507 (Pubitemid 47365293)
40. T Manabe S Mori T Mashiba Y Cao Y Kaji K Iwata S Komatsubara T Yamamoto A Seki H Norimatsu 2009 Eel calcitonin (elcatonin) suppressed callus remodeling but did not interfere with fracture healing in the femoral fracture model of cynomolgus monkeys J Bone Miner Metab 27 295 302 10.1007/s00774-009-0046-x 1:CAS:528:DC%2BD1MXksF2hsrk%3D 19343273
41. GH Nancollas R Tang RJ Phipps Z Henneman S Guide W Wu A Mangood RG Russell FH Ebetino 2006 Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite Bone 38 617 627 10.1016/j.bone.2005.05.003 1:CAS:528:DC%2BD28XjvFSjtr4%3D 16046206
42. Cao YP, Mori S, Mashiba T (2007) Fracture callus under antiresorptive agent treatment evaluated by pQCT. In: Advanced bioimaging technologies in assessment of the quality of bone and scaffold materials techniques and applications. Springer, London, pp 553-566
43. L Kolios S Sehmisch F Daub T Rack M Tezval KM Stuermer EK Stuermer 2009 Equol but not Genistein improves fracture healing in severe experimental osteoporotic bone in rats Planta Med 75 459 465 10.1055/s-0029-1185380 1:CAS:528:DC%2BD1MXlt1yitbw%3D 19241330